Neuromuscular Dynamics

What Neuromuscular Dynamics does

Neuromuscular Dynamics, LLC, doing business as Valero Dexterity, is a La Crescenta, California-based medical device company founded in 2015 by Francisco Valero-Cuevas, PhD, ScD (h.c.) and Erika Valero, RN, CEN. The company markets the Valero Dexterity Test®, an FDA Class I medical device that quantifies neuromuscular ability with a focus on finger and hand dexterity, addressing conditions including chemotherapy-induced peripheral neuropathy, Parkinson's disease, diabetic neuropathies, back pain, and hand and knee osteoarthritis.

The product architecture combines patented measurement hardware with a HIPAA-compliant AES-256 encrypted cloud analytics platform that supports longitudinal patient tracking and standardized testing across single or multi-location deployments. Patent protection on the underlying technology and trademark protection on the Valero Dexterity Test® brand provide intangible-asset differentiation. Validation has been supported by NIH SBIR funding, a NASA grant for athletic training research, an award from the Consortium for Technology & Innovation in Pediatrics (2018), and an NIH-funded clinical trial partnership with SPRI in knee osteoarthritis announced in November 2025.

The company's revenue model rests on three streams: hardware sales or leases of the testing device, transaction-based clinical testing fees billed through insurance following CMS Medicare certification, and recurring cloud analytics subscriptions. The go-to-market targets physical therapists as the primary channel, with secondary reach to neurologists, orthopedic and vascular surgeons, athletic training facilities, and rehabilitation facilities, all of which are SMB-scale clinical practices in the United States.

Name

Neuromuscular Dynamics

Legal name

Neuromuscular Dynamics, LLC

Website

https://valerodexterity.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

Neuromuscular Dynamics, operating as Valero Dexterity, is an FDA Class I medical device company that quantifies neuromuscular and hand-dexterity ability, selling hardware and cloud analytics to physical therapists, neurologists, surgeons, athletic trainers, and rehabilitation facilities across U.S. clinical markets.

Ownership category

akta.pro rank

Product category

Medical Devices - Neuromuscular Diagnostic and Rehabilitation Equipment

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE)

akta.pro secondary industries

Digital Rehabilitation & Physical Therapy Therapeutics (HLACANAJ), Movement Disorders (Parkinson’s, Tremor, Dystonia) (HLAKAIAC), General Personal Training (In-Person & Virtual) (HSADAAAA)

Keywords

• Neuromuscular measurement device
• Clinical rehabilitation technology
• Medical assessment device
• Orthopedic recovery tools
• Neurological diagnostic equipment

Headquarters

HQ city

Glendale

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Medical Device Sales/Leasing: FDA Class I medical device sold or leased to clinical practices. Single and multiple location options available for device setup.
2. Clinical Testing Services: Tests are billable through most insurance providers and existing reimbursement codes. Cloud analytics and secure report delivery included.
3. Cloud Analytics Subscription: HIPAA compliant cloud analytics platform with secure report delivery provided as part of the system offering.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Neuromuscular Dynamics produces the Valero Dexterity Test®, an FDA Class I medical device that quantifies neuromuscular ability by measuring mind-body interaction through compression of a calibrated portable platform. The system is bundled with a HIPAA-compliant cloud analytics platform that delivers secure test reports and scales across single or multiple clinical sites. It is sold or leased to clinical practices for use in orthopedic, neurological, and athletic rehabilitation assessment.

Product overview

Neuromuscular Dynamics offers the Valero Dexterity Test® as its primary product — an FDA Class I medical device that quantifies neuromuscular ability through a patented testing process. The device is used by clinicians to personalize treatments for orthopedic and neurological conditions including ACL injuries, athletic training, chemotherapy-induced neuropathies, Parkinson's disease, hand osteoarthritis, diabetic neuropathies, back pain, and hip/knee reconstruction. The company bundles this hardware with a HIPAA-compliant cloud analytics platform that provides secure report delivery, supporting both single-practice and multi-location clinical deployments. The company also mentions a Leg Dexterity System specifically for knee osteoarthritis treatment, currently being evaluated in an NIH-funded clinical trial.

Differentiator

Problem solved

Functional benefit

Products and services

• Valero Dexterity Test® FDA Class I medical device that quantifies neuromuscular ability by measuring a participant's level and quality of compression on a calibrated portable platform. The device assesses mind-body interaction by measuring neural signals sent through the nervous system during platform stabilization tasks, used by clinicians for orthopedic, neurological, and athletic rehabilitation assessment.
• Valero Dexterity Test® Cloud Analytics Platform HIPAA-compliant cloud analytics platform that delivers secure test reports, scales to single or multiple clinical locations, and enables tracking of clinical recovery and athletic improvement over time. Bundled with the medical device hardware.

Quantifiable outcome

• Quantifies neuromuscular ability to establish functional benchmarks for tracking clinical recovery
• +4 more outcomes

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Steadman Philippon Research Institute (SPRI)coreStrategic or Co-development Partner · 18 November 2025Three-year NIH-funded clinical trial in Vail, Colorado evaluating NMD's Leg Dexterity System for knee osteoarthritis treatment. Compares neuromuscular training using the device against a wobbleboard in improving patient outcomes. Aims to establish non-invasive home-based treatment for knee osteoarthritis.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• Bionik Laboratories: Bionik Labs makes robotic rehabilitation devices (InMotion ARM) for upper-limb neurologic recovery. Comparable as a small, publicly-traded medical device company selling instrumented rehab technology to clinical rehabilitation facilities, with a similar horizontal ambition across neurological indications.
• ProtoKinetics (PKMAS): ProtoKinetics offers the Zeno Walkway and PKMAS gait analysis software for objective clinical gait and balance assessment. Comparable as a niche instrumented gait/balance measurement provider sold to PTs, neurologists, and rehab clinics for objective quantification of movement.
• Delsys (now Artinis): Delsys produces surface EMG sensors and Trigno systems for measuring neuromuscular activity in research, sports, and clinical settings. Overlaps in objective neuromuscular signal capture and the same end-user base of researchers, sports medicine, and rehab clinicians.
• Motek Medical (C-Motion / Motekforce Link): Motek makes instrumented treadmills (GRAIL, C-Mill) and virtual reality rehabilitation systems for gait and balance analysis. Overlaps in the clinical biomechanics and rehab assessment market served by physical therapists and rehabilitation hospitals.

Direct peers

• Tekscan: Tekscan manufactures pressure measurement systems (F-Scan, MatScan) used in clinical gait analysis, orthotics, and rehabilitation. Comparable as an established instrumented clinical measurement hardware company with a multi-vertical application model similar to Valero Dexterity.
• BTS Bioengineering: BTS Bioengineering makes gait, motion, and surface EMG analysis systems (G-Walk, FreeEMG) used in clinical and sports settings. Directly comparable as a maker of instrumented movement and neuromuscular assessment systems sold to rehab and sports medicine clinics.
• Bertec Corporation: Bertec makes force plates, balance platforms, and instrumented treadmills used in clinical biomechanics, concussion baseline testing, and rehabilitation. Comparable as a maker of instrumented clinical measurement devices for neuromuscular and balance assessment, sold to the same clinical buyer profiles.
• Saebo: Saebo makes upper-limb rehabilitation devices and orthoses sold to physical and occupational therapists for stroke, neurological injury, and orthopedic rehab. Comparable as a clinical rehab device company selling instrumented hardware to PTs and OTs for objective measurement and recovery tracking.
• BTE Technologies: BTE Technologies manufactures the PrimusRS and other functional capacity/performance assessment systems used in rehabilitation and occupational medicine. Directly comparable as both companies sell objective, instrumented neuromuscular/functional assessment hardware to PT clinics, sports medicine, and rehab facilities.

Broad incumbents

• Hocoma (DIH Medical): Hocoma is a global incumbent in robotic and sensor-based rehabilitation devices (Lokomat, Armeo, Erigo) used by physical therapists and rehab hospitals. Overlaps in the rehab device market and the same clinical buyer profile, though Hocoma specializes in robotic therapy rather than diagnostic quantification.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Neuromuscular Dynamics